|
⚲
|
| Keyboard |
| Riggs Josh
✚
|
|
|---|---|
| CIK # | 0001956391 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001956391] | |
| 4 | [0001956391] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Oncocyte Corp | |
| Riggs Josh |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oncocyte Corp IMDX
Restricted Stock Units · derivative
|
2026-03-26 | Option exercise | 47,170 | $0.00 | |
|
Oncocyte Corp IMDX
Common Stock
|
2026-03-26 | Tax withheld | 12,310 | $4.11 | 50,594 |
|
Oncocyte Corp IMDX
Common Stock
|
2026-03-26 | Option exercise | 47,170 | ||
|
Oncocyte Corp OCX
Restricted Stock Units · derivative
|
2025-03-26 | Grant | 188,679 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2024-05-20 | Grant | 90,000 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2024-04-11 | Buy | 3,390 | $2.95 | 10,000 |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2023-08-15 | Grant | 40,000 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2023-06-09 | Grant | 800,000 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2023-06-09 | Grant | 350,000 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2023-02-24 | Grant | 116,426 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2023-01-17 | Grant | 257,485 | $0.00 |